[Skip to Content]
[Skip to Content Landing]
Other Articles
April 29, 1950


Author Affiliations

Miami, Fla.

Attending Physician, Head of the Department of Endocrinology and Out Patient Diabetes Clinics. Jackson Memorial Hospital.

JAMA. 1950;142(17):1350-1353. doi:10.1001/jama.1950.02910350020007

Although isolated reports of the occurrence of insulogenic lipodystrophies have been appearing since 1926, the development of local areas of subcutaneous fat atrophy or of persistent hard, nodular swelling at the site of insulin injections is still generally ignored or lightly considered in most textbooks and monographs on diabetes mellitus.

In 1942 Marble and Smith1 reviewed the literature and studied 500 unselected diabetic patients, almost one fifth of whom were found to have areas of lipoatrophy at the site of the insulin injections. After careful histologic studies and other investigations, they could prove no relationship to any of the factors involved in the administration of insulin except possibly that of repeated trauma.

In my personal experience the incidence of insulogenic lipodystrophies reaches close to 60 per cent of all diabetic patients who have been taking daily injections of insulin for periods longer than six months before coming to my

First Page Preview View Large
First page PDF preview
First page PDF preview